Indefinite Delivery Contract SPE2DX15D9408

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The single-award IDC, valued at $499,999,999 and valid through November 2026, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The contracted products support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide. Through this IDC and associated delivery orders, DMS Pharmaceutical Group has demonstrated its capability to provide a diverse array of pharmaceutical items across multiple medical domains, such as oncology treatments, contraceptives, auto-injectors, and specialized medications. The contract does not have any set-aside designations, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal awards for pharmaceutical products and services to the Department of Defense.

The cumulative value of the delivery orders issued under this IDC totals over $200,000, with individual orders ranging from approximately $600 to $65,000. These delivery orders, placed by the DLA's Medical Supply Chain organization, cover a wide variety of pharmaceutical items required to support military healthcare operations. The firm fixed-price structure of the delivery orders provides the DLA with predictable pricing and reliable supply of the necessary medical products from DMS Pharmaceutical Group's established distribution network centered in Park Ridge, Illinois.